The National Institute for Health and Care Excellence (NICE) have released their draft guidelines for the detection and management of hypertension in adults, which are currently out for public consultation. These guidelines lower the threshold for hypertension treatment, which could benefit an additional 450,000 men and 270,000 women.
The draft 2019 guidelines mark a significant departure from the 2011 guidelines; while treatment is still only available for stage 1 hypertension, the 10-year risk of cardiovascular disease threshold has been lowered from 20% to 10%.
The draft guidelines also consider studies which indicate that hypertension treatment would be beneficial for those with a blood pressure below 140/90 mmHg however, ultimately, NICE does not consider these studies to be sufficiently robust due to problems with patient samples.
For further information, please see the full draft guidelines here.